Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors E Bilensoy, C Sarisozen, G Esendağlı, AL Doğan, Y Aktaş, M Şen, ... International journal of pharmaceutics 371 (1-2), 170-176, 2009 | 212 | 2009 |
The untold story of IFN-γ in cancer biology MA Kursunel, G Esendagli Cytokine & growth factor reviews 31, 73-81, 2016 | 201 | 2016 |
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation L Cassetta, K Bruderek, J Skrzeczynska-Moncznik, O Osiecka, X Hu, ... Journal for immunotherapy of cancer 8 (2), 2020 | 158 | 2020 |
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions AM Bruger, A Dorhoi, G Esendagli, K Barczyk-Kahlert, P van der Bruggen, ... Cancer Immunology, Immunotherapy 68, 631-644, 2019 | 146 | 2019 |
Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer G Esendagli, K Bruderek, T Goldmann, A Busche, D Branscheid, ... Lung cancer 59 (1), 32-40, 2008 | 128 | 2008 |
A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of … A Sahin, G Esendagli, F Yerlikaya, S Caban-Toktas, D Yoyen-Ermis, ... Artificial cells, nanomedicine, and biotechnology 45 (8), 1657-1664, 2017 | 91 | 2017 |
Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer D Rama-Esendagli, G Esendagli, G Yilmaz, D Guc Molecular biology reports 41, 2885-2892, 2014 | 77 | 2014 |
Functional exhaustion of CD4+ T cells induced by co‐stimulatory signals from myeloid leukaemia cells D Ozkazanc, D Yoyen‐Ermis, E Tavukcuoglu, Y Buyukasik, G Esendagli Immunology 149 (4), 460-471, 2016 | 76 | 2016 |
Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers K Öztürk, G Esendağlı, MU Gürbüz, M Tülü, S Çalış International journal of pharmaceutics 517 (1-2), 157-167, 2017 | 69 | 2017 |
Myeloid leukemia cells with a B7‐2+ subpopulation provoke Th‐cell responses and become immuno‐suppressive through the modulation of B7 ligands Y Dolen, G Esendagli European journal of immunology 43 (3), 747-757, 2013 | 65 | 2013 |
Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells CT Şengel-Türk, C Hasçiçek, AL Dogan, G Esendagli, D Guc, N Gönül Drug development and industrial pharmacy 38 (9), 1107-1116, 2012 | 64 | 2012 |
Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells A Sahin, D Yoyen-Ermis, S Caban-Toktas, U Horzum, Y Aktas, ... Journal of microencapsulation 34 (7), 659-666, 2017 | 60 | 2017 |
Co‐existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses N Turhan, G Esendagli, O Ozkayar, G Tunali, C Sokmensuer, ... Parasite Immunology 37 (1), 16-22, 2015 | 59 | 2015 |
Identification of circulating MOG-specific B cells in patients with MOG antibodies S Winklmeier, M Schlüter, M Spadaro, FS Thaler, A Vural, R Gerhards, ... Neurology: Neuroimmunology & Neuroinflammation 6 (6), 625, 2019 | 55 | 2019 |
Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles N Erdoğar, G Esendağlı, TT Nielsen, M Şen, L Öner, E Bilensoy International journal of pharmaceutics 509 (1-2), 375-390, 2016 | 55 | 2016 |
Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy G Esendagli, AT Kurne, G Sayat, AK Kilic, D Guc, R Karabudak Journal of neuroimmunology 255 (1-2), 81-84, 2013 | 55 | 2013 |
Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer M Karpuz, M Silindir-Gunay, AY Ozer, SC Ozturk, H Yanik, M Tuncel, ... European Journal of Pharmaceutical Sciences 156, 105576, 2021 | 47 | 2021 |
Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS D Yoyen-Ermis, G Tunali, E Tavukcuoglu, U Horzum, D Ozkazanc, T Sutlu, ... Scientific reports 9 (1), 11697, 2019 | 47 | 2019 |
Expression of chemokine-like receptor 1 (CMKLR1) on J744A. 1 macrophages co-cultured with fibroblast and/or tumor cells: modeling the influence of microenvironment D Rama, G Esendagli, D Guc Cellular immunology 271 (1), 134-140, 2011 | 44 | 2011 |
Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer N Erdoğar, G Esendağlı, TT Nielsen, G Esendağlı-Yılmaz, D Yöyen-Ermiş, ... Journal of drug targeting 26 (1), 66-74, 2018 | 43 | 2018 |